Product Specifications
| Specification | Each / Individual Unit (EA) | Case Packaging (CS) |
| Manufacturer / Brand | B. Braun Medical Inc. / PAB® | B. Braun Medical Inc. / PAB® |
| Manufacturer SKU / Item # | S5104-5264 (EA Unit) | S5104-5264 (Case Pack) |
| NDC Number | 00264-1510-32 (Unit) | 00264-1510-32 (Case) |
| Active Ingredient | 5% Dextrose Hydrous, USP (5 g / 100 mL) | 5% Dextrose Hydrous, USP (5 g / 100 mL) |
| Fill Volume / Container Capacity | 100 mL Fill in 150 mL Bag | 100 mL Fill in 150 mL Bag |
| Caloric Value / Osmolarity | 170 kcal/L / 252 mOsmol/L (Isotonic) | 170 kcal/L / 252 mOsmol/L (Isotonic) |
| Container Type | Flexible PAB® (Partial Additive Bag) | Flexible PAB® (Partial Additive Bag) |
| Material Formulation | PVC-Free / DEHP-Free / Latex-Free | PVC-Free / DEHP-Free / Latex-Free |
| Administration Route | Intravenous (IV) Infusion | Intravenous (IV) Infusion |
| Storage Temperature | 20°C to 25°C (68°F to 77°F) (Controlled Room Temperature) | 20°C to 25°C (68°F to 77°F) (Controlled Room Temperature) |
| Packaging Configuration | 1 Bag (EA) | 64 Bags per Case (CS) |
| Regulatory Category | Prescription-Only (Rx) / Approved NDA | Prescription-Only (Rx) / Approved NDA |
| HCPCS Code | J7070 | J7070 |
Key Features & Clinical Applications
-
Pharmacy Admixture Design: Features a 100 mL fill in a 150 mL capacity PAB® container, leaving 50 mL of dead-space head room for convenient, sterile additive admixture (e.g., concentrated electrolytes, antiemetics, antibiotics) without overflowing.
-
Biocompatible Eco-Friendly Materials: Formulated without PVC, DEHP, or natural rubber latex. Prevents leaching of plasticizers and avoids chemical sorption of lipophilic drug molecules into the container walls.
-
Caloric & Hydration Support: Provides an immediate source of bioavailable calories (170 kcal/L) and free water to restore tissue hydration and combat carbohydrate deficiency.
-
Dual Port Integrity: Equipped with a self-sealing medication injection port and a separate sterile administration set port for reliable aseptic processing.
⚠️ Hyperglycemia & Fluid Overload Warning: Administer with caution in patients with overt or subclinical diabetes mellitus. Rapid IV administration of dextrose solutions can induce severe hyperglycemia, hyperosmolar syndrome, hypervolemia, or electrolyte disturbances (e.g., hypokalemia, hyponatremia).
⚠️ Corn Allergy Contraindication: Solutions containing dextrose are contraindicated in patients with known hypersensitivity or allergies to corn or corn products.
⚠️ Admixture Compatibility Check: Always consult compatibility references prior to adding drugs to 5% Dextrose Injection. Do not administer simultaneously with blood products through the same infusion set due to pseudoagglutination risk.
